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COSMIC, The Catalogue Of Somatic Mutations In Cancer
[http://cancer.sanger.ac.uk], is one of the largest reposi-
tories for somatic mutational events in human cancer.
Data in COSMIC are curated from multiple sources,
including from over 14,310 scientific publications, and are
alongside data from the Cancer Genome Project at the
Sanger Institute and global international consortia, such as
The Cancer Genome Atlas and the International Cancer
Genome Consortium. The COSMIC database currently
accommodates over 300,000 mutations across 750,000
analyzed samples from 21,850 genes (COSMIC v60, July
2012). The Cancer Gene Census [http://cancer.sanger.ac.
uk/cancergenome/projects/census/] is a list of almost 500
known cancer genes for which mutations have been iden-
tified as causally implicated in cancer. These genes are
prioritized for full literature curation.
The collection of whole exome and genome sequencing
data in COSMIC continues to grow at a rapid pace. There
are: 17,614 coding mutations, 84,747 non-coding variants
in 396 whole genome screens; 121,619 coding mutations
and 12,949 non-coding variants as result of 1,266 full
exome sequencing; 3,512 structural mutations derived
from 77 rearrangement screens. The data overview for
each whole genome screen is presented using Circos, for
example, the NCI-H209 Circos summary [http://cancer.
sanger.ac.uk/cosmic/sample/overview?id=688013].
Analyzing information from whole genome sequencing
can greatly enhance the chance of discovering novel genes
implicated in human cancer. Unlike hot spot screening of
gene regions where somatic mutations are most frequent,
the use of whole genome data can identify all mutations in
all genes, providing much more expansive annotations to
recurrence analysis as used to discover new cancer genes.
For instance, there are recurrent somatic mutations identi-
fied in genes, for example: SPOP in 19 prostate samples;
SDK1 in 20 large-intestine samples.
There are several ways to access and analyze the data in
COSMIC. The website allows data viewing in a genomic
context supported by GBrowse while maintaining our
gene-centric perspective. New additional features include
a filter for excluding identified SNPs from the 1000 Gen-
omes Project, and displaying Pfam domains and links to
biological pathways for selected genes.
For mining a large dataset, COSMICmart (an instance of
BioMart) is a tool for downloading user-customized data-
sets federated with external databases such as Ensembl
and Uniprot. Moreover, we provide data export in multi-
ple formats and Oracle database export through the FTP
site [ftp://ftp.sanger.ac.uk/pub/CGP/cosmic].
In addition to somatic mutation data, we have integrated
the data from the Genomics of Drug Sensitivity in Cancer
Project [http://www.cancerrxgene.org], which is screening
a wide range of anticancer therapeutics against over 1,000
genetically characterized human cancer cell lines.
Data analysis is becoming increasingly challenging due
to the rapid expansion in cancer genome sequencing capa-
city. COSMIC is a major cancer genetics resource aiming
to help such investigations, providing a centralized somatic
mutations database with a wide suite of tools for its
examination.
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